首页> 外文期刊>Clinical microbiology and infection: European Society of Clinical Microbiology and Infectious Diseases >Emergence and control of an outbreak of infections due to Panton-Valentine leukocidin positive, ST22 methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit
【24h】

Emergence and control of an outbreak of infections due to Panton-Valentine leukocidin positive, ST22 methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit

机译:在新生儿重症监护病房中出现和控制因Panton-Valentine leukocidin阳性,ST22耐甲氧西林的金黄色葡萄球菌而引起的感染暴发

获取原文
获取原文并翻译 | 示例
           

摘要

Methicillin resistant Staphylococcus aureus (MRSA) infection can cause significant morbidity and mortality in neonates. We investigated a nosocomial MRSA outbreak in a neonatal intensive care unit (NICU), using a novel typing method. Following two fatal cases, in May 2011, a prospective outbreak investigation was conducted, involving neonates, mothers and healthcare workers in a large tertiary NICU in Sydney. MRSA isolates were characterized by antimicrobial susceptibility testing, a multiplex PCR-based reverse line blot (mPCR/RLB) binary typing system and other molecular typing methods. Over 7months, 14 neonates were colonized with MRSA and six infected: three with superficial lesions and three with life-threatening disease, including the two index cases, who died despite empirical treatment with vancomycin. Isolates from 15 neonates were indistinguishable by RLB typing and identified as a PVL-producing ST22 SCCmec IV MRSA strain, which was resistant to gentamicin and trimethoprim-sulphamethoxazole. The outbreak strain was also isolated from one healthcare worker, one environmental swab and one father, but the source remained obscure. During the same period several different non-multiresistant and multiresistant MRSA strains were isolated from five neonates, five mothers (including two whose infants were colonized with the outbreak strain), one father, three healthcare workers and two environmental swabs. Rapid turnaround time of typing results allowed us to recognize and define the outbreak and implement targeted infection control interventions. PVL-producing ST22 SCCmec IV MRSA appears to be a virulent and highly transmissible pathogen in the NICU, which was difficult to control.
机译:耐甲氧西林金黄色葡萄球菌(MRSA)感染可导致新生儿的高发病率和死亡率。我们使用新型分型方法调查了新生儿重症监护病房(NICU)的医院内MRSA暴发。在发生两起致命病例之后,2011年5月,对悉尼一家大型第三级重症监护病房中的新生儿,母亲和医护人员进行了一次前瞻性暴发调查。 MRSA分离物通过抗菌药敏测试,基于多重PCR的反向线印迹(mPCR / RLB)二元分型系统和其他分子分型方法进行表征。在7个月以上的时间里,有14例新生儿感染了MRSA,其中6例感染:3例患有浅表病变,3例危及生命,其中包括2例索引病例,尽管接受了万古霉素的治疗,但仍死亡。通过RLB分型无法区分来自15例新生儿的分离株,并鉴定为对庆大霉素和甲氧苄啶-硫代甲恶唑有抗药性的产生PVL的ST22 SCCmec IV MRSA菌株。疫情也从一名医护人员,一名环境拭子和一名父亲身上分离出来,但来源仍然不清楚。在同一时期,从五名新生儿,五名母亲(包括两名婴儿被暴发暴发菌定植),一名父亲,三名医护人员和两只环境拭子中分离出了数种不同的非多抗和多抗性MRSA菌株。快速键入结果的周转时间使我们能够识别和定义爆发并实施针对性的感染控制干预措施。产生PVL的ST22 SCCmec IV MRSA在重症监护病房中似乎是一种高毒力和高传播性病原体,难以控制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号